Schedule 13G ownership disclosure

ADAPTIVE BIOTECHNOLOGIES CORP

Common Stock, par value $0.0001 per share · CUSIP: 00650F109

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Integrated Core Strategies (US) LLC

    Shares: 5,622,214.00 · Class: 3.8%

  • Millennium Management LLC

    Shares: 6,292,634.00 · Class: 4.3%

  • Millennium Group Management LLC

    Shares: 6,292,634.00 · Class: 4.3%

  • Israel A. Englander

    Shares: 6,292,634.00 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-006314
Form type
SCHEDULE 13G/A
Filer
Adaptive Biotechnologies Corp
CIK
CIK 1478320
Filed
Jan 27, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub